| Description | 1. Mulberroside has nephroprotective, hypoglycemic, and antidiabetic effects. 2. Mulberroside A is a glycosylated stilbene of oxyresveratrol; thus, the deglycosylation of Mulberroside A resulted in enhanced inhibition of melanogenesis. 3. Mulberroside A has anti-inflammatory antiapoptotic effects. by decreasing the expressions of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6 and inhibiting the activation of NALP3, caspase-1, and nuclear factor-κB and the phosphorylation of extracellular signal-regulated protein kinases, the c-Jun N-terminal kinase, and p38. |
| Target activity | Monophenolase:1.29 μmol/L |
| Synonyms | 桑皮苷 A, 桑皮苷A |
| molecular weight | 568.52 |
| Molecular formula | C26H32O14 |
| CAS | 102841-42-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 55 mg/mL (96.74 mM) |
| References | 1. Wang C P , Zhang L Z , Li G C , et al. Mulberroside a protects against ischemic impairment in primary culture of rat cortical neurons after oxygen-glucose deprivation followed by reperfusion[J]. Journal of Neuroscience Research, 2014, 92(7):944-954. |